下游操作对肺癌筛查依从性的影响
本研究基于Optum去标识化Clinformatics Data Mart数据库,纳入2015年1月1日至2020年11月30日期间接受肺癌筛查(LCS)且筛查后无肺癌的个体,评估LCS后下游影像和有创操作的频率与费用,并分析其与重复LCS的关联。结果显示17.7%的LCS检查(5,414/30,521)引发下游检查,其中4个月内胸部CT最常见(9.1%,2,769/30,521);校正患者特征后,发生下游诊断性影像或有创操作与重复年度LCS可能性降低相关(校正OR分别为0.38,95%CI 0.34-0.44;0.75,95%CI 0.63-0.90)。作者认为下游影像和有创操作是LCS依从性的潜在障碍。
要点
- 17.7%(5,414/30,521)的LCS检查引发下游检查,4个月内胸部CT最常见(9.1%)。
- 下游诊断性影像与重复年度LCS可能性降低相关(校正OR 0.38,95%CI 0.34-0.44)。
- 下游有创操作与重复年度LCS可能性降低相关(校正OR 0.75,95%CI 0.63-0.90)。
核心结论
- LCS后下游影像和有创操作是LCS依从性的潜在障碍;减少LCS假阳性和降低下游操作的患者费用可能有助于确保下游检查不阻碍筛查依从性。
研究设计与样本
- 回顾性数据库研究,纳入2015年1月1日至2020年11月30日期间接受LCS且筛查后无肺癌的个体23,640例(30,521次LCS检查),数据来自Optum去标识化Clinformatics Data Mart数据库,采用广义估计方程模型分析重复LCS与下游操作及患者特征的关联。
诊断标准与关键数值
- 主要结局为指数LCS后1年内重复筛查;次要分析评估指数LCS后2年内重复筛查。
- 下游诊断性影像与重复年度LCS的校正OR为0.38(95%CI 0.34-0.44)。
- 下游有创操作与重复年度LCS的校正OR为0.75(95%CI 0.63-0.90)。
临床应用与阅片要点
- 原文结论指出,减少LCS假阳性和降低下游操作的患者费用可能有助于确保下游检查不阻碍筛查依从性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: (1) Evaluate downstream procedures after lung cancer screening (LCS), including imaging and invasive procedures, in screened individuals without screen-detected lung cancer. (2) Determine the association between repeat LCS and downstream procedures and patient characteristics.
METHODS: Individuals receiving LCS between January 1, 2015, and November 30, 2020, from Optum's deidentified Clinformatics Data Mart Database were included. Individuals with lung cancer after LCS were excluded. We determined frequency and costs of downstream procedures after LCS, including diagnostic imaging (chest CT, PET, or CT using fluorine-18-2-fluoro-2-deoxy-D-glucose imaging) and invasive procedures (bronchoscopy, needle biopsy, thoracic surgery). A generalized estimating equation was used to model repeat LCS as a function of downstream procedures and patient characteristics. The primary outcome was repeat screening within 1 year of index LCS, and a secondary analysis evaluated the outcome of repeat screening with 2 years of index LCS.
RESULTS: In all, 23,640 individuals receiving 30,521 LCS examinations were included in the primary analysis; 17.7% of LCS examinations (5,414 of 30,521) prompted downstream testing, with chest CT within 4 months being most common (9.1%, 2,769 of 30,521). At multivariable analysis adjusted for patient characteristics, the occurrence of a downstream diagnostic imaging test or invasive procedure was associated with a decreased likelihood of repeat annual LCS (adjusted odds ratio, 95% confidence interval: 0.38, 0.34-0.44; adjusted odds ratio, 95% confidence interval: 0.75, 0.63-0.90, respectively).
DISCUSSION: Downstream imaging and invasive procedures after LCS are potential barriers to LCS adherence. Efforts to reduce false-positives at LCS and reduce patient costs from downstream procedures are likely necessary to ensure that downstream workup after LCS does not discourage screening adherence.
引用
- Tailor TD, Bell S, Carlos RC, et al. The Impact of Downstream Procedures on Lung Cancer Screening Adherence. J Am Coll Radiol. 2023. PMID: 37586471. doi:10.1016/j.jacr.2023.08.003
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。